Science

Re-Engineering of Human Aging: How Biotech Is Decoupling Lifespan from Decline

For centuries, aging was accepted as an unyielding biological tax on existence. Modern biogerontology, however, is orchestrating a fundamental shift in...

imtiaz  | ArticlePaid
3 min read · 3 days ago
3 0
Re-Engineering of Human Aging: How Biotech Is Decoupling Lifespan from Decline  | ArticlePaid

For centuries, aging was accepted as an unyielding biological tax on existence. Modern biogerontology, however, is orchestrating a fundamental shift in medical philosophy: aging is no longer viewed as an inevitable natural decline, but as a complex, malleable biological disease mechanism that can be targeted, delayed, or even partially reversed. The overarching goal of longevity science is not merely extending total lifespan (the overall number of years lived), but maximizing healthspan—the period of life spent free from chronic disease, frailty, and cognitive decay.

The Cellular Machinery Behind Aging

To manipulate aging, researchers first had to map its underlying causes. Biogerontologists generally categorize aging into several core interconnected mechanisms:

Continue reading this Article by imtiaz

Join our community to access the full story. Creating an account is completely free and only takes a moment.

  • Read unlimited free publications across the platform
  • Directly support independent journalists and authors
  • Join discussions, leave reactions, and save your favorites

Responses (0)

Sign in to share your thoughts.

Sign in